Cochrane · systematic review · CD007445

Chlorpromazine for psychosis induced aggression or agitation

Ahmed, U, Jones, H, Adams, CE · Cochrane Database of Systematic Reviews · 2010 · Cochrane Library

SchizophreniaAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
5
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 1 · 16.7%Very low 5 · 83.3%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

CHLORPROMAZINE compared to HALOPERIDOL for psychosis induced aggression or agitation

Population: patients with psychosis induced aggression or agitation
6 questions
OutcomeEffectEvidenceStatus / GRADE
Global outcome: Number of additional injections ‐ 2‐4 injections
CHLORPROMAZINE vs HALOPERIDOL
RR 0.9 [0.52, 1.55]1 study · 30 participantsVery low
Downgraded: risk of bias
Global outcome: Number of additional injections ‐ 5 or more
CHLORPROMAZINE vs HALOPERIDOL
RR 0.75 [0.2, 2.79]1 study · 30 participantsVery low
Downgraded: risk of bias
Adverse effects ‐ cardiovascular ‐ hypotension
CHLORPROMAZINE vs HALOPERIDOL
RR 5 [0.26, 96.13]1 study · 30 participantsVery low
Downgraded: risk of bias
Adverse effects ‐ movement disorders ‐ extrapyramidal side effects
CHLORPROMAZINE vs HALOPERIDOL
no estimate extracted1 study · 30 participantsUngraded
Adverse effects ‐ seizures
CHLORPROMAZINE vs HALOPERIDOL
RR 3 [0.13, 68.26]1 study · 30 participantsVery low
Downgraded: risk of bias
Leaving the study early
CHLORPROMAZINE vs HALOPERIDOL
RR 2 [0.2, 19.78]1 study · 30 participantsVery low
Downgraded: risk of bias